PGIM Jennison Health Sciences Fund - Class C (PHLCX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
12.21
-0.39 (-3.10%)
Mar 10, 2025, 1:24 PM EST
-33.89%
Fund Assets 1.68B
Expense Ratio 1.96%
Min. Investment $1,000
Turnover n/a
Dividend (ttm) 5.25
Dividend Yield 41.45%
Dividend Growth 174.48%
Payout Frequency Annual
Ex-Dividend Date Dec 20, 2024
Previous Close 12.60
YTD Return 1.28%
1-Year Return 8.49%
5-Year Return 96.56%
52-Week Low n/a
52-Week High n/a
Beta (5Y) 0.69
Holdings 49
Inception Date Jun 30, 1999

About PHLCX

The Fund's investment strategy focuses on Health/Biotech with 1.85% total expense ratio. The minimum amount to invest in Prudential Sector Funds, Inc: PGIM Jennison Health Sciences Fund; Class C Shares is $1,000 on a standard taxable account. Prudential Sector Funds, Inc: PGIM Jennison Health Sciences Fund; Class C Shares seeks long-term capital appreciation. PHLCX invests primarily in equity-related securities of U.S. firms engaged in the following industries: hospitals, nursing and residential care, health and medical insurance carriers, pharmaceutical and medicine companies, and medical equipment firms.

Fund Family PGIM Funds Cl C
Category Health
Performance Rating Above Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol PHLCX
Share Class Class C
Index S&P Composite 1500 Health Care TR

Performance

PHLCX had a total return of 8.49% in the past year. Since the fund's inception, the average annual return has been 13.38%, including dividends.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
PHLQX Class R6 0.77%
PHSZX Class Z 0.86%
PHLAX Class A 1.13%
PJHRX Class R 1.48%

Top 10 Holdings

51.61% of assets
Name Symbol Weight
Eli Lilly and Company LLY 13.44%
UnitedHealth Group Incorporated UNH 5.29%
Boston Scientific Corporation BSX 5.00%
Neurocrine Biosciences, Inc. NBIX 4.56%
argenx SE ARGX 4.46%
Vertex Pharmaceuticals Incorporated VRTX 4.17%
Intuitive Surgical, Inc. ISRG 4.17%
AstraZeneca PLC AZN 3.63%
Bristol-Myers Squibb Company BMY 3.58%
Novo Nordisk A/S NVO 3.33%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 20, 2024 $5.25148 Dec 20, 2024
Dec 20, 2023 $1.91322 Dec 20, 2023
Dec 20, 2022 $0.61624 Dec 20, 2022
Dec 20, 2021 $14.02528 Dec 20, 2021
Dec 20, 2019 $1.43164 Dec 20, 2019
Dec 20, 2018 $4.77761 Dec 20, 2018
Full Dividend History